Showing results (201-210 of 297) with videos related to
Sort By:
Pageof 30
Current Medicinal Chemistry|July 30, 2015
The Pros and the Cons for the Use of Silybin-Rich Oral Formulations in Treatment of Liver Damage (NAFLD in Particular)Natalia Rosso, Veronica Marin, Antonio Giordani, et al.Diagnostics (Basel, Switzerland)|October 23, 2021
The Relevance of SOCS1 Methylation and Epigenetic Therapy in Diverse Cell Populations of Hepatocellular CarcinomaLoraine Kay D Cabral, Peter Andrew C Reyes, Lory S Crocè, et al.The Journal of Pharmacology and Experimental Therapeutics|August 10, 2006
Molecular determinants in the transport of a bile acid-derived diagnostic agent in tumoral and nontumoral cell lines of human liverAntonin Libra, Cristina Fernetti, Vito Lorusso, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 19, 2011
Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transferGiulia Bortolussi, Lorena Zentilin, Gabriele Baj, et al.Proteomics. Clinical Applications|August 5, 2015
Modern strategies to identify new molecular targets for the treatment of liver diseases: The promising role of Proteomics and Redox Proteomics investigationsAndrea Scaloni, Erika Codarin, Vittorio Di Maso, et al.BMC Gastroenterology|October 13, 2009
Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatologyNorberto C Chavez-Tapia, Felix I Tellez-Avila, Giorgio Bedogni, et al.Biology|June 28, 2023
Bilirubin-Induced Transcriptomic Imprinting in Neonatal HyperbilirubinemiaJohn Paul Llido, Emanuela Fioriti, Devis Pascut, et al.Liver International : Official Journal of the International Association for the Study of the Liver|November 20, 2021
Glycosylated 4-methylumbelliferone as a targeted therapy for hepatocellular carcinomaGisela Weiz, Maria I Molejon, Mariana Malvicini, et al.Journal of Medical Virology|April 22, 2006
Hepatitis B virus genotypes, core promoter variants, and precore stop codon variants in patients infected chronically in North-Eastern ItalyGianna Dal Molin, Albino Poli, Lory S Crocè, et al.Endocrine Connections|October 24, 2018
Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesityDevis Pascut, Sofia Tamini, Silvia Bresolin, et al.Pageof 30